| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 28.39▲ | 28.39▲ | 28.39▲ | 29.24▼ | 28.33▲ |
| MA10 | 26.94▲ | 26.94▲ | 26.94▲ | 28.84▲ | 27.54▲ |
| MA20 | N/A | N/A | N/A | 28.26▲ | 26.05▲ |
| MA50 | N/A | N/A | N/A | 27.33▲ | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | 0.055▲ | N/A |
| RSI | N/A | N/A | N/A | 60.889▲ | 69.069▲ |
| STOCH | N/A | N/A | N/A | 89.040▲ | 90.651▲ |
| WILL %R | N/A | N/A | N/A | -42.092 | -11.230▲ |
| CCI | N/A | N/A | N/A | 59.281 | 142.431▲ |
|
Friday, January 23, 2026 10:22 AM
The Rights Offering will include an over-subscription privilege which permits each holder of Subscription Rights that exercises such holder’s basic Subscription Right in full to purchase additional ...
|
|
Thursday, August 21, 2025 06:00 AM
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/07/26 | 29.52 | 29.52 | 28.73 | 28.8777 | 3,347 |
| 01/07/26 | 29.62 | 29.62 | 29.4425 | 29.4425 | 1,891 |
| 30/06/26 | 29.51 | 29.51 | 29.49 | 29.5052 | 7,018 |
| 29/06/26 | 28.91 | 29.194 | 28.91 | 29.194 | 5,757 |
| 26/06/26 | 28.7601 | 29.2003 | 28.7601 | 29.2003 | 853 |
| 25/06/26 | 28.71 | 28.8183 | 28.71 | 28.8183 | 2,057 |
| 24/06/26 | 28.33 | 28.40 | 28.30 | 28.3911 | 3,340 |
| 23/06/26 | 28.205 | 28.27 | 28.205 | 28.2198 | 2,099 |
| 22/06/26 | 28.475 | 28.475 | 28.32 | 28.3658 | 5,010 |
| 18/06/26 | 28.39 | 28.4183 | 28.36 | 28.4183 | 7,672 |
|
|
||||
|
|
||||
|
|